CELL ONE
DEAD

Serial Number

97700280

Owner

Cellares Corporation

Attorney

Bobby A. Ghajar

Filing Date

Dec 1, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CELL ONE Trademark

Serial Number: 97700280

CELL ONE is a trademark filed by Cellares Corporation on December 1, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Cellares Corporation (38 trademarks)

South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

December 1, 2022

Registration Date

Not Registered

Goods & Services

Bio processing and process development equipment for the manufacturing of therapeutics and biologics-based drug-delivery vehicles; Downloadable computer software for accessing a database featuring information in the medical field, specifically, cell therapy related information; Downloadable software applications for telephones, tablets, computers allowing the access to information and consulting in the field of health; Downloadable software applications for telephones, tablets, computers allowing the access to information, monitoring and management systems for the manufacture of advanced therapy and cell therapy medications; Downloadable databases in the field of manufacture of advanced therapy and cell therapy medications; Downloadable electronic publications in the nature of electronic questionnaires on the area of advanced therapy and cell therapy medications; Scientific and laboratory apparatus and instruments for the manufacturing of autologous and allogeneic biological cell therapies in the nature of laboratory centrifuges, cell sorting apparatus, bioreactors for laboratory use, and parts and fittings for all of the aforesaid goods; fully integrated laboratory apparatus and computer systems for use in autologous and allogenic cell therapy manufacturing, and parts and fittings therefor; Fully integrated laboratory apparatus and computer systems for use in autologous and allogenic cell therapy manufacturing, and parts and fittings therefor; Downloadable software for the manufacturing of autologous and allogeneic cell therapies; Downloadable software for automating the operations of biotechnological instruments used with manufacturing equipment for biological cell therapies; downloadable software for the execution, monitoring, analysis of cell therapy manufacturing workflows as well as process development workflows; downloadable software for the processing, separation, isolation, enrichment, depletion, cell activation, genetic modification, detection, screening, analysis and counting of material; downloadable software for generating electronic batch records for cell therapies

Medical equipment for the manufacturing of autologous and allogeneic biological cell therapies for medical and non-veterinary purposes, namely, fully integrated system for use in the creation of biological cell therapies for medical purposes; disposable single-use containers for solutions used for the manufacturing of autologous and allogeneic biological cell therapies, namely, bags, pouches, cartridges, rigid and semi-rigid containers for concentrates and solutions in solid or liquid form for medical use; the foregoing excludes containers that are used to transport or ship temperature-sensitive goods, medicines, pharmaceuticals, and biologics in an insulated or temperature controlled manner

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 12, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 12, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 12, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 26, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 26, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2023 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Apr 11, 2023 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Apr 11, 2023 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 5, 2022 NWOS
NEW APPLICATION ENTERED
Dec 5, 2022 NWAP